IBD is a condition of an overactive immune system and is often treated with immune modification or immune suppression to achieve a goal of symptom control and disease modification. IBD patients taking some medications may be more susceptible to infection, but this depends on the type of medications they are taking. To date, there are limited data about patients with IBD who have COVID-19.

References:

1.https://www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disease-and-ulcerative-colitis/